Whalerock Point Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $273K | Hold |
3,295
| – | – | 0.06% | 162 |
|
|
2025
Q1 | $267K | Hold |
3,295
| – | – | 0.06% | 160 |
|
|
2024
Q4 | $297K | Hold |
3,295
| – | – | 0.07% | 150 |
|
|
2024
Q3 | $326K | Hold |
3,295
| – | – | 0.08% | 138 |
|
|
2024
Q2 | $305K | Hold |
3,295
| – | – | 0.08% | 124 |
|
|
2024
Q1 | $313K | Hold |
3,295
| – | – | 0.09% | 138 |
|
|
2023
Q4 | $294K | Sell |
3,295
-35
| -1% | -$3.13K | 0.09% | 128 |
|
|
2023
Q3 | $243K | Sell |
3,330
-500
| -13% | -$36.5K | 0.08% | 133 |
|
|
2023
Q2 | $319K | Hold |
3,830
| – | – | 0.11% | 116 |
|
|
2023
Q1 | $292K | Hold |
3,830
| – | – | 0.11% | 115 |
|
|
2022
Q4 | $318K | Sell |
3,830
-500
| -12% | -$41.5K | 0.13% | 104 |
|
|
2022
Q3 | $343K | Hold |
4,330
| – | – | 0.15% | 97 |
|
|
2022
Q2 | $322K | Hold |
4,330
| – | – | 0.14% | 105 |
|
|
2022
Q1 | $389K | Hold |
4,330
| – | – | 0.14% | 102 |
|
|
2021
Q4 | $485K | Hold |
4,330
| – | – | 0.17% | 92 |
|
|
2021
Q3 | $544K | Buy |
4,330
+35
| +0.8% | +$4.4K | 0.21% | 81 |
|
|
2021
Q2 | $582K | Hold |
4,295
| – | – | 0.22% | 78 |
|
|
2021
Q1 | $583K | Hold |
4,295
| – | – | 0.26% | 73 |
|
|
2020
Q4 | $605K | Buy |
4,295
+3,816
| +797% | +$538K | 0.29% | 69 |
|
|
2020
Q3 | $479K | Sell |
479
-3,316
| -87% | -$3.31M | 0.26% | 71 |
|
|
2020
Q2 | $425K | Buy |
3,795
+232
| +7% | +$26K | 0.25% | 76 |
|
|
2020
Q1 | $276K | Hold |
3,563
| – | – | 0.2% | 89 |
|
|
2019
Q4 | $339K | Hold |
3,563
| – | – | 0.18% | 104 |
|
|
2019
Q3 | $272K | Buy |
+3,563
| New | +$272K | 0.15% | 121 |
|